Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYGENFIT: new market research data highlight potential of elafibranor in PBCPREV STORYMatriSys Announces Positive Results From a Phase I Study of MSB-0221 for the Topical Treatment of Atopic Dermatitis